BeiGene receives positive CHMP opinion for Tevimbra
BeiGene (ONC) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion ...
Researchers identify potential drug combinations to improve breast cancer treatment: Q&A with professor of pharmacology
Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...
Frontiers29d
Case Report: Metastatic succinate dehydrogenase–deficient gastrointestinal stromal tumor treated with chemotherapy and immune checkpoint inhibitor
Rapid metastatic relapse after subtotal gastrectomy was resistant to imatinib. The patient received four cycles of cisplatin, etoposide, and pembrolizumab followed by pembrolizumab maintenance with a ...